Portfolio Companies
Beacon Sciences, LLC
is a biopharmaceutical company focused on specialized binding assays using supra-molecular recognition and chemiluminescence.
Mimetic Solutions, LLC
is a biopharmaceutical company specializing in smart-release polymers that are highly specific for triggered release of desired chemicals.
Auxano Biomedical, LLC
is a biopharmaceutical company with a unique focus on wound healing - the reestablishment of tissues such as skin and the cornea.
Pure Protein L.L.C.
has developed a unique method to produce soluble HLA protein from human cell lines for use in drug target discovery and bio-therapeutic development.
Choncept
is a biotech company focused on development of new technology to produce chondroitin from fermentation of recombinant bacteria to replace the current chondroitin source of beef and other animal by-products.
Pure Transplant Solutions, L.L.C.
A SUBSIDIARY OF PURE PROTEIN, L.L.C.
is using HLA protein to develop diagnostics, devices, and therapeutics which will eliminate rejection in organ transplants.
Entercel, Ltd.
is a biotech company focused on regulating cell resistance to drugs and agrochemicals, allowing for enhanced product performance.
Pure Vaccine Solutions, L.L.C.
A SUBSIDIARY OF PURE PROTEIN, L.L.C
is using HLA protein to discover valuable new vaccine targets, improve existing vaccines, and design clinical trials for vaccine candidates.
Heparinex
is a biotech company focused on development of novel recombinant synthesis of compounds for the anticoagulation market to replace the current heparin source of beef and other animal byproducts.
Receptor Logic
has developed an integrated diagnostic and therapeutic approach to be used in the design of customized anti-cancer and infectious disease treatments for individual patients.
Hyalose, Ltd.
has developed unique capabilities for the recombinant production of hyaluronic acid.
Selenium, Ltd.
is focused on the application of Selenium as an anti-bacterial agent and a anti-cellular, free radical chemistry technology.